首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1657415

硫酸軟骨素市場 - 全球產業規模、佔有率、趨勢、機會和預測，按來源、應用、地區和競爭細分，2020-2030 年

Chondroitin Sulfate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source, By Application, By Region and Competition, 2020-2030F

出版日期: 2025年02月17日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球硫酸軟骨素市場價值為 11 億美元，預計在預測期內將呈現強勁成長，到 2030 年的複合年成長率為 3.35%。預期硫酸軟骨素的需求將受到對營養保健品的需求不斷成長和骨關節炎發病率不斷上升的推動。藥用級硫酸軟骨素主要用於治療泌尿道感染 (UTI)、白內障和骨關節炎，預計將推動對該來源的整體需求。此外，它還以藥物的形式用來降低血糖水平，防止腫瘤擴散，並促進肝功能。此外，預計其在治療骨關節炎和其他幾種疾病方面的需求不斷成長將有助於整體市場的擴張。

市場概況
預測期	2026-2030
2024 年市場規模	11億美元
2030 年市場規模	13.4 億美元
2025-2030 年複合年成長率	3.35％
成長最快的領域	牛
最大的市場	亞太地區

硫酸軟骨素由長鏈糖組成，包括葡萄醣醛酸和N-乙醯半乳醣胺。它天然存在於人體結締組織、軟骨和關節中，在其結構和功能中發揮著至關重要的作用。經常服用硫酸軟骨素可以改善關節功能。此外，這種用途廣泛的產品還可用於獸醫學和作為治療乾眼症的眼藥水。

肉品業對硫酸軟骨素的市場需求有重大影響。隨著肉類消費量的增加和寵物產業對肉類來源的需求增加，市場經歷了成長。腎臟、脾臟、肝臟、腦和肺等動物副產品具有重要的營養價值，並用於各個產業。

例如，日本、中國和印度等國家利用動物腺體和器官用於醫療目的。動物內臟經過加工可以生產出牛脂、肉粉、肥料和寵物食品。豬和牛的肝臟萃取物可作為膳食補充劑和維生素 B12 的來源，用於治療不同類型的貧血。將含有過多骨頭或油含量高的魚類廢棄物轉化為工業原料和飼料。此外，軟骨是膠原蛋白和硫酸軟骨素的寶貴來源，可用於藥品、營養品、化妝品和食品。

肉類和肉源的使用量不斷增加，導致動物屠宰數量增加。由於軟骨素來自屠宰後收集的軟骨，這種物質的製造商受益匪淺。骨關節炎是老年人最常見的肌肉骨骼疾病之一，它是一種影響關節、限制運動並引起疼痛的退化性疾病。

硫酸軟骨素通常用於緩解疼痛、減緩病情進展和緩解骨關節炎症狀。美國疾病管制與預防中心估計，每 5 個美國成年人中就有 1 個，即約 5,320 萬人患有某種形式的關節炎。在 100 多種不同類型的關節炎中，骨關節炎 (OA) 是最常見的，影響 3,250 萬美國成年人。關節炎的廣泛流行造成了巨大的社會和個人成本，凸顯了有針對性的醫療解決方案和支持的必要性。隨著骨關節炎在美國、英國等工業化國家變得越來越普遍，對硫酸軟骨素的需求預計將持續成長。

主要市場促進因素

製藥業對硫酸軟骨素的需求不斷成長

化妝品產業對硫酸軟骨素的需求不斷成長

主要市場挑戰

價格波動與原物料採購

主要市場趨勢

越來越重視運動營養

分段洞察

來源洞察

區域洞察

Global Chondroitin Sulfate Market was valued at USD 1.10 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 3.35% through 2030. The demand for chondroitin sulfate is projected to be driven by the rising demand for nutraceutical goods and the growing incidences of osteoarthritis. Pharmaceutical-grade chondroitin sulfate is mostly used to treat Urinary Tract Infections (UTIs), cataracts, and osteoarthritis, which is expected to fuel the overall demand for the source. In addition, it is utilized in the form of medications to lower blood sugar levels, prevent tumor spread, and promote liver function. Moreover, the general market expansion is anticipated to be aided by the increasing demand for its use in the treatment of osteoarthritis and several other disorders.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.10 Billion
Market Size 2030	USD 1.34 Billion
CAGR 2025-2030	3.35%
Fastest Growing Segment	Bovine
Largest Market	Asia Pacific

Chondroitin sulfate is composed of a long chain of sugars, including glucuronic acid and N-acetylgalactosamine. It is naturally present in human connective tissues, cartilage, and joints, playing a crucial role in their structure and function. Regular consumption of chondroitin sulfate has been associated with improved joint functioning. Furthermore, this versatile product finds applications in veterinary medicine and as an eye drop for dry eyes.

The meat industry has a significant impact on the market demand for chondroitin sulfate. With the rising consumption of meat and the high demand for meat-based sources from the pet industry, the market has experienced growth. Animal by-products, such as kidneys, spleen, liver, brains, and lungs, offer significant nutritional value and are utilized in various industries.

For instance, countries like Japan, China, and India use animal glands and organs for medical purposes. Animal intestines are processed to produce tallow, meat meal, fertilizer, and pet food. Liver extract from pigs and cattle serves as a dietary supplement and a source of vitamin B12 for the treatment of different types of anemia. Fish waste that contains excessive bones or has a high oil content is transformed into industrial sources and feed. Additionally, cartilage serves as a valuable source of collagen and chondroitin sulfate, which find applications in pharmaceuticals, nutraceuticals, cosmetics, and food products.

The use of meat and meat sources is on the rise, leading to an increased number of animal slaughters. As chondroitin source is derived from cartilage collected after slaughter, the manufacturers of this substance have benefitted tremendously. Osteoarthritis, one of the most prevalent musculoskeletal conditions affecting the elderly, is a degenerative disease that affects the joints, restricting motion and causing pain.

Chondroitin sulfate is commonly used to relieve pain, slow the progression of the condition, and alleviate osteoarthritis symptoms. The CDC estimates that 1 in 5 U.S. adults, or approximately 53.2 million individuals, are affected by some form of arthritis. Among the more than 100 different types of arthritis, osteoarthritis (OA) is the most prevalent, impacting 32.5 million U.S. adults. The widespread prevalence of arthritis results in significant societal and personal costs, underscoring the need for targeted healthcare solutions and support. With osteoarthritis becoming more common in industrialized nations like the U.S. and the U.K., among others, the demand for chondroitin sulfate is expected to continue growing.

Key Market Drivers

Growing Demand of Chondroitin Sulfate in Pharmaceutical Industry

The demand for chondroitin sulfate in the pharmaceutical industry is steadily increasing due to its well-documented efficacy in alleviating joint pain and inflammation. This versatile compound is a crucial ingredient found in numerous over-the-counter dietary supplements specifically formulated for promoting optimal joint health.

All countries are confronted with significant challenges in preparing their health and social systems to fully capitalize on the demographic shift towards an aging population. By 2050, it is projected that 80% of older individuals will reside in low- and middle-income countries, underscoring the growing pressures these regions will face. The rate at which populations are aging is accelerating, outpacing historical trends. In 2020, for the first time, individuals aged 60 and older outnumbered children under 5 years old, highlighting the demographic shift occurring globally. Between 2015 and 2050, the proportion of the world's population aged 60 and above is expected to nearly double, increasing from 12% to 22%. This shift will require substantial adaptation in healthcare, social services, and infrastructure to meet the evolving needs of older populations. As the population continues to age and awareness about preventive healthcare rises, manufacturers of both foods and supplements are anticipated to exhibit an even greater demand for chondroitin sulfate in the forthcoming years. This surge in demand is expected to have a significant impact on the chondroitin sulfate market, fostering its growth and development.

The expanding application of chondroitin sulfate in the pharmaceutical industry, combined with the heightened consumer consciousness regarding joint health and an increased emphasis on preventive care propel the demand for this, the demand for this remarkable substance. will undoubtedly continue to propel the demand for this remarkable substance. Additionally, ongoing research endeavors exploring novel applications of chondroitin sulfate are poised to further contribute to the market's expansion and evolution. A significant 77% of individuals experiencing joint pain report that it adversely impacts their daily activities. Osteoarthritic pain is a major contributor to workplace absenteeism, with sufferers missing more than 16 workdays annually. Additionally, 66% of individuals with arthritis pain state that it affects their self-esteem. Osteoarthritis significantly diminishes the quality of life for those affected, often leading to emotional challenges such as depression, anxiety, and social isolation. In fact, 55% of people with osteoarthritic pain indicate that their condition prevents them from pursuing their personal dreams and professional ambitions. According to the World Health Organization (WHO), by 2050, an estimated 40 million individuals will be severely disabled due to osteoarthritis, highlighting the growing societal and economic burden of this condition.

Growing Demand of Chondroitin Sulfate in Cosmetic Industry

Chondroitin sulfate, a compound gaining immense popularity in the cosmetic industry, is renowned for its remarkable efficacy in skin hydration and anti-aging properties. Its ability to retain moisture, improve skin elasticity, and reduce the appearance of wrinkles has made it a coveted ingredient in numerous skincare products.

Moreover, chondroitin sulfate has found its way into the realm of hair care products, thanks to its remarkable capability to promote healthier and shinier hair. As consumer demand for natural and effective ingredients in cosmetics continues to soar, the chondroitin sulfate market is experiencing significant growth. Approximately 85% of men and 33% of women will experience alopecia at some stage in their lives. Globally, an estimated 35 million men and 21 million women are currently affected by hair loss.

The escalating application of chondroitin sulfate within the cosmetic industry, in conjunction with the rising consumer awareness regarding the benefits of natural ingredients, is expected to sustain this demand. Furthermore, ongoing research into new applications of chondroitin sulfate is poised to further bolster the market.

In conclusion, the surging demand for chondroitin sulfate in the cosmetic industry serves as a key driver for the growth of the global chondroitin sulfate market. With an increasing consumer inclination towards natural and effective cosmetic products, this trend is anticipated to persist and shape the industry's landscape.

Key Market Challenges

Price Fluctuations and Raw Material Sourcing

One of the key challenges confronting the Chondroitin Sulfate market is the volatility in the prices of raw materials. The primary sources of Chondroitin Sulfate are terrestrial and marine animals such as bovines, porcines, chickens, and sharks. The cost of these raw materials is subject to fluctuation due to various factors, including changes in supply, seasonal variations, and environmental impacts.

For instance, overfishing can lead to a decrease in the availability of shark cartilage, driving up its price. This not only affects the market dynamics but also raises concerns about the sustainability and conservation of marine resources. Additionally, regulatory measures aimed at protecting endangered species can further limit the sourcing of certain animal-derived raw materials, adding complexity to the supply chain.

Moreover, the sourcing of raw materials poses another challenge for the Chondroitin Sulfate market. The production of Chondroitin Sulfate heavily relies on the availability of animal sources, which can be influenced by several factors. Geopolitical issues, such as trade restrictions and political instability, can disrupt the supply of raw materials from certain regions. Environmental regulations aimed at preserving biodiversity and reducing environmental impact can also impact the availability and sourcing practices of animal-derived raw materials.

Furthermore, ethical considerations around animal welfare play a significant role in the sourcing of raw materials for Chondroitin Sulfate. Consumers and stakeholders are increasingly concerned about the ethical treatment of animals and demand transparency in the sourcing practices of products. This includes adherence to animal welfare standards, responsible sourcing, and traceability of raw materials.

In some cases, religious and cultural practices can further complicate the sourcing of specific raw materials. Certain animal-derived products may not be acceptable to consumers following specific dietary laws or cultural practices, limiting the market potential for those products.

Key Market Trends

Growing Emphasis on Sports Nutrition

Sports nutrition is a specialized branch of nutritional science that delves into the intricacies of athletes' and fitness enthusiasts' diets and nutritional requirements. It aims to optimize performance, facilitate efficient recovery, and minimize the risk of injuries.

One notable ingredient that has gained popularity in sports nutrition supplements is chondroitin sulfate. Renowned for its joint health benefits, chondroitin sulfate plays a crucial role in maintaining the structural integrity of joints and tissues. This attribute proves particularly advantageous for individuals engaged in high-impact sports, where joint support is paramount.

As awareness grows regarding the importance of joint health, chondroitin sulfate is increasingly being incorporated into sports nutrition products. Its and potential to enhance joint function and promote overall joint health is highly valued, considering the strain and stress that regular exercise and sports activities can place on joints. By including chondroitin sulfate in their supplement regimens, athletes and fitness enthusiasts can potentially safeguard their joints and maintain their healthy function.

Moreover, emerging studies suggest that chondroitin sulfate may possess anti-inflammatory effects, which could effectively manage exercise-induced inflammation and further support the recovery process.

Given this trend, manufacturers in the chondroitin sulfate market have an opportunity to capitalize on the growing demand by developing and marketing products specifically tailored for athletes and fitness enthusiasts. These products could encompass a wide range, from joint health supplements to post-workout recovery aids, ensuring that the unique nutritional needs of this active population are met effectively.

Segmental Insights

Source Insights

Based on the category of source, the bovine segment emerged as the dominant segment in the global market for chondroitin sulfate in 2024. This is attributed to the increased usage of the source in a variety of application industries, including pharmaceutical, personal care & cosmetics, and nutraceuticals globally. In the pharmaceutical industry, chondroitin sulfate derived from sharks is widely used in the formulation of drugs for joint health and osteoarthritis treatment.

Similarly, in the nutraceutical industry, it is utilized as a dietary supplement to support joint function and mobility. Additionally, chondroitin sulfate from sharks finds application in animal feed industries to promote healthy cartilage development in livestock. However, it is important to note that the shark population is currently regarded as endangered, which poses challenges to the expansion of the sector and highlights the need for sustainable sourcing alternatives.

Regional Insights

Asia Pacific emerged as the dominant region in the Global Chondroitin Sulfate Market in 2024, holding the largest market share in terms of value. The market for chondroitin sulfate in the Asia-Pacific region is primarily driven by the expanding demand for supplements made with this compound from the healthcare and food & beverage industries. As more people become conscious of the health benefits associated with chondroitin sulfate, the market in the region is expected to grow significantly.

In the Asia-Pacific chondroitin sulfate market, the share is divided into different segments based on application, source, and country. In terms of source, the market is categorized into three groups: bovine, marine, and porcine. Among these, the bovine segment is projected to maintain the highest market share. This is mainly attributed to the increasing demand for supplements containing chondroitin sulfate obtained from bovines in the healthcare industry.

The growth of the chondroitin sulfate market in the Asia-Pacific region is expected to be driven by factors such as rising consumer awareness about the health benefits, growing demand for dietary supplements, and increasing investment in healthcare infrastructure. These factors, along with the expanding application of chondroitin sulfate in various industries, are likely to contribute to the continued growth and development of the market in the region.

Key Market Players

TSI Group Ltd.
Qingdao Wan Toulmin Biological Products Co., Ltd
Hebei Sanxin Steel Structure Co Ltd
Bioiberica S.A.U.
Sigma-Aldrich, Inc.
Sino Siam Biotechnique Company Limited
Bio-gen Extracts Private Limited
Zpd A/S
SEIKAGAKU CORPORATION
BRF SA

Report Scope:

In this report, the Global Chondroitin Sulfate Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chondroitin Sulfate Market, By Source:

Bovine
Poultry
Synthetic
Swine
Shark

Chondroitin Sulfate Market, By Application:

Nutraceuticals
Personal Care & Cosmetics
Animal Feed
Pharmaceuticals
Others

Chondroitin Sulfate Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chondroitin Sulfate Market.

Available Customizations:

Global Chondroitin Sulfate Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Impact of COVID-19 on Global Chondroitin Sulfate Market

5. Global Chondroitin Sulfate Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Source (Bovine, Poultry, Synthetic, Swine, Shark)
- 5.2.2. By Application (Nutraceuticals, Personal Care & Cosmetics, Animal Feed, Pharmaceuticals, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. Asia Pacific Chondroitin Sulfate Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Source
- 6.2.2. By Application
- 6.2.3. By Country
6.3. Asia Pacific: Country Analysis
- 6.3.1. China Chondroitin Sulfate Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Source
    - 6.3.1.2.2. By Application
- 6.3.2. India Chondroitin Sulfate Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Source
    - 6.3.2.2.2. By Application
- 6.3.3. Australia Chondroitin Sulfate Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Source
    - 6.3.3.2.2. By Application
- 6.3.4. Japan Chondroitin Sulfate Market Outlook
  - 6.3.4.1. Market Size & Forecast
    - 6.3.4.1.1. By Value
  - 6.3.4.2. Market Share & Forecast
    - 6.3.4.2.1. By Source
    - 6.3.4.2.2. By Application
- 6.3.5. South Korea Chondroitin Sulfate Market Outlook
  - 6.3.5.1. Market Size & Forecast
    - 6.3.5.1.1. By Value
  - 6.3.5.2. Market Share & Forecast
    - 6.3.5.2.1. By Source
    - 6.3.5.2.2. By Application

7. Europe Chondroitin Sulfate Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Source
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Chondroitin Sulfate Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Source
    - 7.3.1.2.2. By Application
- 7.3.2. Germany Chondroitin Sulfate Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Source
    - 7.3.2.2.2. By Application
- 7.3.3. Spain Chondroitin Sulfate Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Source
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Chondroitin Sulfate Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Source
    - 7.3.4.2.2. By Application
- 7.3.5. United Kingdom Chondroitin Sulfate Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Source
    - 7.3.5.2.2. By Application

8. North America Chondroitin Sulfate Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Source
- 8.2.2. By Application
- 8.2.3. By Country
8.3. North America: Country Analysis
- 8.3.1. United States Chondroitin Sulfate Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Source
    - 8.3.1.2.2. By Application
- 8.3.2. Mexico Chondroitin Sulfate Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Source
    - 8.3.2.2.2. By Application
- 8.3.3. Canada Chondroitin Sulfate Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Source
    - 8.3.3.2.2. By Application

9. South America Chondroitin Sulfate Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Source
- 9.2.2. By Application
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Chondroitin Sulfate Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Source
    - 9.3.1.2.2. By Application
- 9.3.2. Argentina Chondroitin Sulfate Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Source
    - 9.3.2.2.2. By Application
- 9.3.3. Colombia Chondroitin Sulfate Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Source
    - 9.3.3.2.2. By Application

10. Middle East and Africa Chondroitin Sulfate Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Source
- 10.2.2. By Application
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Chondroitin Sulfate Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Source
    - 10.3.1.2.2. By Application
- 10.3.2. Saudi Arabia Chondroitin Sulfate Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Source
    - 10.3.2.2.2. By Application
- 10.3.3. UAE Chondroitin Sulfate Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Source
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Chondroitin Sulfate Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

16.1. TSI Group Ltd.
- 16.1.1. Business Overview
- 16.1.2. Company Snapshot
- 16.1.3. Products & Services
- 16.1.4. Financials (As Reported)
- 16.1.5. Recent Developments
16.2. Qingdao Wan Toulmin Biological Products Co., Ltd
16.3. Hebei Sanxin Steel Structure Co Ltd
16.4. Bioiberica S.A.U.
16.5. Sigma-Aldrich, Inc.
16.6. Sino Siam Biotechnique Company Limited
16.7. Bio-gen Extracts Private Limited
16.8. Zpd A/S
16.9. SEIKAGAKU CORPORATION
16.10. BRF SA